Literature DB >> 7527647

Circulating cytokines in sickle cell patients during steady state.

H Croizat1.   

Abstract

Plasma levels of GM-CSF, IL-3, IL-6 and IL-1 (alpha,beta) were investigated in steady-state sickle cell patients. We find that SS patients with low levels of HbF (< 9% [LFSS]) are characterized by elevated plasma GM-CSF, whereas in patients with high levels of HbF (HFSS), GM-CSF is not detectable. In contrast, HFSS patients exhibited increased plasma IL-3 (m = 84.8 +/- 57 pg/ml), whereas LFSS patients had lower or no detectable plasma IL-3, IL-1(alpha,beta) and IL-6 were also detected in plasma from some SS patients, but there was no correlation with HbF levels. Normal controls tested negative for all cytokines, except for one individual positive for IL-3. These results are compatible with a model in which the level of haemopoietic stress determines the level of participation of GM-CSF or IL-3 in the regulation of SS circulating BFU-E.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527647     DOI: 10.1111/j.1365-2141.1994.tb08318.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  30 in total

1.  The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.

Authors:  Tohru Ikuta; Adekunle D Adekile; Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Betsy Clair; Abdullah Kutlar; Nadine Odo; C Alvin Head
Journal:  Blood Cells Mol Dis       Date:  2011-09-25       Impact factor: 3.039

Review 2.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

Review 3.  Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Authors:  Dachuan Zhang; Chunliang Xu; Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

4.  High levels of neopterin and interleukin-3 in sickle cell disease patients.

Authors:  L Rodrigues; F F Costa; S T O Saad; H Z W Grotto
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

5.  Plasma zinc levels inversely correlate with vascular cell adhesion molecule-1 concentration in children with sickle cell disease.

Authors:  Solo R Kuvibidila; Manuel Sandoval; Juan Lao; Maria Velez; Lolie Yu; David Ode; Renée Gardner; Gerald Lane; Raj P Warrier
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

Review 6.  Emerging biobehavioral factors of fatigue in sickle cell disease.

Authors:  Suzanne Ameringer; Wally R Smith
Journal:  J Nurs Scholarsh       Date:  2011-01-04       Impact factor: 3.176

Review 7.  Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.

Authors:  Varun Sagi; Donovan A Argueta; Stacy Kiven; Kalpna Gupta
Journal:  Complement Ther Med       Date:  2020-05-11       Impact factor: 2.446

8.  Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin.

Authors:  Andreia A Canalli; Renata F Proença; Carla F Franco-Penteado; Fabiola Traina; Tatiana M Sakamoto; Sara T O Saad; Nicola Conran; Fernando F Costa
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

9.  Differential modulation of adhesion molecule expression by hydroxycarbamide in human endothelial cells from the micro- and macrocirculation: potential implications in sickle cell disease vasoocclusive events.

Authors:  Sandrine Laurance; Pauline Lansiaux; François-Xavier Pellay; Michelle Hauchecorne; Arndt Benecke; Jacques Elion; Claudine Lapoumeroulie
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

10.  Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease.

Authors:  Joan D Beckman; John D Belcher; Julie V Vineyard; Chunsheng Chen; Julia Nguyen; M Osita Nwaneri; M Gerard O'Sullivan; Evin Gulbahce; Robert P Hebbel; Gregory M Vercellotti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.